Event Calendar
Meet us at one the following industry events
LATEST EVENTS
Webinar with Loxo@Lilly | A Precision Medicine Roadmap for Rx and CDx Co-development and Regulatory Approval in Japan
In this webinar, Dr. Susanne Rhoades of Loxo@Lilly discussed co-developing precision therapies and companion diagnostics, challenges encountered when applying for co-approval in Japan, and how her team used AI-powered genomic knowledgebases to make risk and benefit decisions. Watch the recording
Precision Medicine World Conference (PMWC) | January 25-27, 2023 | Silicon Valley, CA
PMWC is the foremost precision medicine forum, showcasing latest practical content that helps close the knowledge gap among different sectors. Meet the Genomenon team at PMWC 2023. Learn more here
BIO One-on-One Partnering – JPM Week
The Genomenon leadership team will be participating at the BIO 1×1 Partnering during JP Morgan week 2023. Learn more here
Webinar | Curating the Human Genome to Advance Early Identification of Rare Diseases
In this webinar, Mark Kiel, MD, PhD, and Brittnee Jones, PhD discussed a critical challenge in genomic variant interpretation – the lack of actionable information – and how a unique combination of AI-driven technology and expert scientific review has emerged as the only viable way to curate all variants in the human genome. Watch the recording
ASHG 2022
ASHG provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. ASHG members and leading scientists from around the world are selected to present their research findings at invited, plenary, platform, and poster sessions. Visit our ASHG 2022 event page to learn about our CoLab presentations, and ways to connect with our team in Los Angeles. Learn more
APHL Newborn Screening Symposium
The APHL 2022 Newborn Screening Symposium will again be in-person. It will also have an online component with live streamed sessions from Tacoma. It will address state, national and international newborn screening, genetic testing and policy issues important to public health newborn screening systems. Genomenon is speaking at this event. Learn more
The International Conference on Newborn Sequencing
The Genomes2People Research Program has partnered with GenomeWeb’s Precision Medicine Leaders’ Summit to produce this event, which will be in-person and live streamed. The International Conference on Newborn Sequencing will cover key issues surrounding the adoption of newborn sequencing to detect rare genetic diseases and other disorders in neonates, from technical considerations to operational challenges, ethical concerns, and the implications for long-term clinical care. Learn more
Clinical Biomarkers & World CDx Summit | September 26-29 | Boston, MA
The 12th World Clinical Biomarkers & CDx Summit returns at a crucial time for the entire precision & targeted drug development industry. Across 2 days of comprehensive content, 65+ global expert speakers shared fresh data paired with inspiring stories from innovative partnership collaborations to help you overcome your most pressing challenges and accelerate curative medicine for heterogeneous patient populations. Genomenon is a proud sponsor of this event. Learn more
Webinar: Using Mastermind’s New ClinVar Integration to Accelerate Clinical Diagnoses
Watch the latest Mastermind webinar with Dr. Mark Kiel and Program Quality Manager, Anna McGill, where they demonstrate how to how to streamline variant interpretation workflow within a single easily searchable interface using the new ClinVar integration. Watch the recording
Next Generation Dx Summit
The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Now in its fourteenth year, the Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important topics for the industry. Learn more
The AI-Driven Drug Discovery Summit
Several high-profile partnerships between pharma and AI companies have materialized recently, but with commercial validation of approaches taking place, improving technologies will expedite this process. The inaugural AI Driven Drug Discovery Summit will highlight key approaches to implementing novel AI technologies to expanding datasets. With this landscape rapidly evolving, the need to determine where and how AI can most add value has never been stronger. By uniting leaders from pharma, biotech, AI-technology companies and academia, this forum allows you to create a clear strategic vision and ambition regarding the use of AI to optimize drug discovery. Learn more
Cancer Genomics Consortium 2022
The Cancer Genomics Consortium (CGC) is committed to providing high quality education and promoting best laboratory practices in clinical cancer genomics. Genomenon’s team of Pharma specialists will be in St. Louis for this event. Meet us at our booth or contact us to schedule a meeting. Learn more
Overcoming Challenges of CNV and Sequence Variant Interpretation in the Clinical Lab
This webinar with Kai Lee Yap, PhD, FACMG, from Lurie Children’s Hospital and Genomenon’s Brittnee Jones, PhD illustrates with real-world clinical cases, how CNV and sequence variant interpretation challenges have been positively impacted by the Mastermind Genomic Search Engine. Watch the recording
World Orphan Drug Congress
The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies. Meet the Genomenon team at Booth 137 at WODC in Boston. Learn more
Precision Medical World Conference
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine. Meet the Genomenon team at PMWC 2022. Learn more
Ask the Masterminds: ACMG Classification for Rare Disease
Program manager Jeffrey Bissonnette and medical science liaison Lauren Chunn demonstrate how Mastermind can be used to efficiently score germline variants according to ACMG/AMP criteria, and describe how Mastermind creates data-driven certainty for rare disease clinicians. Watch the recording
BIO International Convention 2022
Join the Genomenon team and life science experts at Bio 2022 in San Diego to explore ‘limitless’ possibilities and seize today’s unprecedented momentum to realize a bio-tech drive future where we can cure disease, and create a healthier world through science. Schedule a meeting with us through the Bio 1×1 Partnering portal. Learn more
European Human Genetics Conference – ESHG
The ESHG Conference provides a platform for the dissemination of the most exciting advancements in the field of human genetics and to foster the education of the upcoming generation of human geneticists. Meet the Genomenon team at our booth or contact us to schedule a meeting at the event. Learn more
ALS Drug Development | May 24-26, 2022 | Boston, MA
Putting a spotlight on exciting pathways for therapeutic intervention, developing targeted therapeutics for stratified patient populations, and investigating alternative primary outcome measures, the ALS Drug Development Summit is uniquely positioned to provide strategic insight into accelerating effective therapies to patients. Meet the Genomenon team in Boston or contact us to schedule a meeting. Learn more
Rare Disease Innovation and Partnering Summit
Solution-focused strategies surrounding patient access, reimbursement, commercialization, launch, partnering and more in this unique, all-access format. Join experts across the rare disease community, in-person or virtually, to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs. Connect with the Genomenon team at this hybrid event to learn more about our Disease-Specific Curated Content for rare diseases. Learn more
BIO-IT World Conference & Expo
The Bio-IT World Conference & Expo is the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Genomenon is a 2019 and 2022 Best of Show winner at BIO-IT World. Learn more
Labroots Genetics Virtual Week 2022
Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology and human health, Molecular Diagnostics, exploring best laboratory practices and novel diagnostic applications, and Precision Medicine, spanning innovative technologies and solutions transforming healthcare and changing how patients are treated today. Valued Genomenon partners will be speaking, as well as CSO Mark Kiel, MD, PhD. View the on-demand presentations
Neuroimmunology Drug Development Summit
The 4th Neuroimmunology Drug Development Summit is the timely, industry-definitive forum providing actionable insights to target neuroimmunological mechanisms and advance drug development addressing neuroinflammation. Meet the Genomenon team in Boston to learn more about our ai-driven solutions for clinical labs and pharma. Learn more
Precision Medicine Institute – Live Briefing
The Precision Medicine Institute’s weekly live briefings feature experts covering today’s most timely and critical precision medicine topics that hospital and health system executives need to understand. CSO Mark Kiel, MD, PhD will be speaking about ‘Curating the Genome to Drive Precision Diagnosis in Clinical Care’. Watch the recording
AI in Drug Discovery, Biomarker Development and Advanced R&D
The primary goal of this webinar is to give a complete picture of the industry environment in terms of AI usage in drug discovery, clinical research, and other elements of pharmaceutical research and development. This comprehensive overview will present trends and insights in the form of mindmaps and infographics, and benchmark the performance of key players who shape the industry’s space and relationships. CSO Mark Kiel, MD, PhD, will be speaking about an ‘AI-Driven Locus-Specific Database for 35 ALS-Associated Genes’. Watch the recording
Mastermind Masterclass: Search Companion for Chrome
Watch Genomenon’s chief technology officer Steve Schwartz and director of customer success Dr. Brittnee Jones as they explored the functionality of Search Companion and the benefits it provides for anyone wishing to take genomic variant research and interpretation to the next level. Watch the recording
10th Neurodegenerative Drug Development Summit
From exploring emerging therapeutic approaches like protein degraders and scrutinizing the latest biomarker research to determine which one is most useful against neurodegenerative disease indications to taking a multi-omic approach to target discovery, the 10th Neurodegenerative Drug Development Summit will siphon critical insights from Biogen, AbbVie, Roche, Takeda, Novartis, Alector, Alzheon and more to help you supercharge therapeutic development through to approval for neurodegenerative disease patients around the world. If we missed you at this event, email us here.
ACMG Annual Meeting 20222
The ACMG Annual Clinical Genetics Meeting is where geneticists gather for the best four days of medical genetics. Watch the Exhibit Theater presentation with Inozyme Pharma, ‘Curating the Genome Curating the Genome to Drive Precision Diagnosis in Clinical Care for Rare Disease’ by visiting our Genomenon ACMG 2022 event page.
BIO CEO & Investor Conference
For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies. Join us in 2022 – either in person or online – for one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. To schedule a meeting with our leadership team, email us here.
BIO One-on-One Partnering – JPM Week 2021
Connect with the Genomenon leadership team during JP Morgan 2022 via the BIO One-on-One Partnering platform. Learn more about our work with leading pharmaceutical companies, and how Genomenon’s Genomic Landscapes deliver a profound understanding of the genetic drivers and clinical attributes of any genetic disease, from neurodegenerative and rare diseases to cancer. To schedule a meeting, email us here.
Neurodevelopmental Drug Development Summit
Connect with our team during the inaugural Neurodevelopmental Drug Development Summit, the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups paving the way towards symptomatic and successful disease modifying treatments. Developing new outcome measures that measure incremental change and target the neurodevelopmental disease itself, driving design innovation across disease-specific clinical trials, and capitalizing on the advances in new therapeutic modalities to drastically change the lives of patients in need. Learn more
3rd Annual Gene Therapy for Neurological Disorders Meeting
Revolutionize the Development & Delivery of Neurological Gene Therapies. Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS. Learn more
Webinar with Inozyme Pharma | Locus-Specific Patient Databases for Rare Disease: A Computational Approach
In our latest Pharma webinar, Genomenon’s Chief Science Officer, Dr. Mark Kiel was joined by Dr. Gus Khursigara, VP of Medical Affairs and Clinical Strategy at Inozyme Pharma to discuss how a computational approach to curation of medical evidence has emerged as an efficient and economical method to systematically identify and analyze all reported cases of a rare disease and interpret all associated genetic variants. Watch the recording
Biomarkers for Rare Diseases Summit
Uniting world leaders developing novel therapeutics for rare disease, the inaugural Biomarkers for Rare Diseases Summit will address learnings, challenges and future directions at the only summit dedicated to approaches to identify, test and proof clinical biomarkers in rare disease for regulatory approval. Genomenon is a proud sponsor of this event where CSO Dr. Mark Kiel is serving as a Featured Chair Speaker. Learn more
Translating Discovery to Therapy | International Ectodermal Dysplasias Research Conference | Charlotte, NC
This conference will bring together clinicians and researchers to present and discuss approaches and future directions for translating science to therapy for hereditary conditions that affect skin, eyes, hair and teeth. The goal is to advance our ability to better manage these conditions through the development of novel and effective diagnostics and therapies. Dr. Mark Kiel is speaking at this event. Learn more
Clinical Biomarkers & World CDx Summit
Across 2 days of comprehensive content, 65+ global expert speakers shared fresh data paired with inspiring stories from innovative partnership collaborations to help you overcome your most pressing challenges and accelerate curative medicine for heterogeneous patient populations. Genomenon is a proud sponsor of this event. Learn more
Industry Speaker Series: From Academia to Industry with Mark Kiel, Co-Founder and CSO, Genomenon
Register for a Keck Graduate Institute virtual Industry Talk with Dr. Mark Kiel, Co-Founder and Chief Scientific Officer at Genomenon. Dr. Kiel completed his M.D., Ph.D., and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was more likely to emerge out of industry. In 2014, he founded Genomenon – an AI-driven genomics company addressing the challenge of connecting clinicians with medical evidence to help diagnose patients with genetic diseases and cancer. Learn more
Bio-IT World 2021 | Boston, MA
Connect with our team at Bio-IT World 2021 to learn how Genomenon is harnessing the power of artificial intelligence and machine learning technologies to maximize and accelerate drug discovery and development efforts from early stage to adoption to practical application. Meet with us at Booth 226. Learn more
Webinar | Genomic Biomarker Selection for Companion Diagnostic Development
Learn from Experts At Illumina, Gilead, Loxo Oncology, and Taiho Oncology on Leveraging NGS for CDx Testing. Hosted by Genomenon, our guest speakers will highlight the current applications, upcoming trends, and future challenges of CDx development in the modern precision medicine era. Watch the recording
ESHG 2021 | European Human Genetics Conference
Genomenon was proud to participate at ESHG 2021, and we encourage you to learn more about the Mastermind Genomic Search Engine from our customers at the On-Demand Presentation (watch the presentation now), download free genomic interpretation resources, and connect with our team. Learn more
Children’s Hospital Genomics Roundtable
Streamlining Genetic Diagnosis and Treatment Plans for Rare Disorders and Pediatric Cancer Predisposition
In this Children’s Hospital genomics roundtable discussion, experienced laboratory directors and clinicians gathered from a variety of institutions leading the charge in pediatric genomics research, including St. Jude Children’s Research Hospital, Children’s Hospital of Colorado, Nationwide Children’s Hospital, and Memorial Sloan Kettering Cancer Center. Watch the recording
ACMG 2021 – The Annual Clinical Genetics Meeting
Genomenon proudly sponsored of 2021, and encourage you to learn more about the Mastermind Genomic Search Engine from our customers at the ACMG Product Theater presentation, download free resources, and watch our Children’s Hospital Genomics Roundtable virtual event. Learn more
The Challenge of Variant Interpretation: Leveraging Genetic and Clinical Evidence to Improve the Diagnosis of Rare Diseases
In this webinar, speakers from Limbus Medical Technologies, MGZ, and Genomenon share their perspectives on what is necessary to successfully accept challenges in clinical routine and what tools are available and needed to accelerate and improve the diagnostic process.
Rapid WGS: How Rady Children’s Institute Is Increasing Diagnostic Yield and Improving Outcomes
In this webinar, Dr. Stephen Kingsmore, President and CEO of Rady Children’s Institute for Genomic Medicine, gave an executive overview of the two-time world-record-setting Rady rWGS method, followed by a deeper examination of the institute’s analysis and interpretation pipeline by Dr. Katarzyna (Kasia) Ellsworth. The presentation included a demonstration of the Rady literature curation process that is powered by the Mastermind Genomic Search Engine.
Watch the Recording
NSGC Genomic Technologies and Health IT SIG Webinar Series: AI 101
The National Society of Genetic Counselors hosted a CEU-eligible webinar titled Artificial Intelligence (AI) 101 with guest speaker Dr. Mark Kiel, co-founder and Chief Science Officer at Genomenon. Attendees learned about the fundamentals of Artificial Intelligence and its implication in medical genomics—now and in the future.
Watch the recording
How to Gain Immediate Insight into Clinically Relevant Evidence with Congenica and Mastermind
In this webinar, Helen Savage, DipRCPath, Deputy Head of Clinical Services at Congenica and Genomenon CSO Mark Kiel, MD, PhD, look at a key part of the clinical interpretation workflow and reveal how a combination of new tools is helping to break through the interpretation bottleneck, enabling you to instantly identify and analyze genetic evidence found across the complete corpus of scientific articles, faster and with greater confidence than ever before.
View the recording here
INDUSTRY EVENTS
World Orphan Drug Congress | Washington, D.C.
The Genomenon leadership team attended The World Orphan Drug Congress USA, an event where innovation and expertise is showcased, solutions are found and learning is done. If you were unable to connect with us via the event platform or our booth, please schedule a meeting: email us here.
LabRoots | Drug Discovery & Development 2021
LabRoots and the Drug Discovery planning committee are pleased to announce the 4th Annual Drug Discovery & Development Virtual Conference. Genomenon Co-Founder and Chief Science Officer, Dr. Mark Kiel presented, ‘Comprehensive ALS Genomic Landscape | Implications for Drug Discovery and Development’. In this webinar, Dr. Kiel highlighted the results of Genomenon’s curation efforts and what it may mean for improving ALS diagnosis and treatment.
Watch the recording
LabRoots Laboratory Automation & Informatics Virtual Event
At this virtual event, Founder & CSO Dr. Mark Kiel presented at the LabRoots Laboratory Automation & Informatics Virtual Event: ‘Comprehensive Genomic Association Data for Genetic Variant Interpretation: A Computational Approach’.
Learn more and watch on-demand
LabRoots Genetics Virtual Week | Genomic Landscapes: Leveraging Genetic Evidence throughout the Pharma Pipeline
Realizing the promise of Precision Medicine requires both a deep understanding of the landscape of genomic evidence and an understanding of the molecular drivers that influence all aspects of the drug development pipeline. Using real-world examples, Dr. Kiel demonstrates how Genomenon has overcome these obstacles and is being used by pharmaceutical companies to provide invaluable insight into the genomic drivers of disease.
Learn more and register to watch on-demand
Precision Medicine World Conference – Silicon Valley
At this event, Founder & CSO Dr. Mark Kiel presented, ‘Curating the Entire Human Genome at Scale’. PMWC is a gathering of recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors.
View Dr. Kiel’s presentation
MATTER Startup Showcase
Genomenon co-founder and CSO Mark Kiel, MD, PhD, presented real-world examples to demonstrate how Mastermind Genomic Landscapes empower pharmaceutical researchers and translational teams to understand rare diseases at the molecular level.
Learn more about MATTER
PARTNERING EVENTS
Biotechgate Digital Partnering 2021
Biotechgate Digital Partnering supports the business development of Pharma, Biotech, Medtech and Digital Health companies. The Genomenon leadership team participated in the five days of virtual partnering. Connect with us to learn more: email us here
3rd Annual Neuroimmunology Drug Development Summit
Translate Key Technological & Mechanistic Neuroimmunology Advances into the Clinic
The 3rd Neuroimmunology Drug Development Summit is the industry’s definitive and unrivalled forum focused solely on pushing the frontiers of targeting neuroinflammation for CNS Indications. As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology-targeted therapeutics. Connect with our team to learn more: email us here
Clinical Biomarkers & World CDx Europe
Over the course of two days, the 11th annual Clinical Biomarkers & CDx Europe Summit will bring all stakeholders together to fast-track precision medicine through clinically validated biomarkers and companion diagnostics partnerships in Europe. The two-tracks meeting will tackle key conversations spanning biomarker discovery through to drug-Dx market penetration, enabling you with innovation to power pipeline progression. Connect with our leadership team at CBCDx EU to learn more about Genomenon. Learn more
Neurodegenerative Drug Development Summit 2021
9th Neurodegenerative Drug Development Summit is the industry’s definitive and unrivaled forum focused on revealing hot and promising pockets of innovation in drug discovery for neurodegenerative diseases and combating translational challenges by shining a light on pioneering companies leading the way to meet this dire medical need. Visit Genomenon’s virtual booth and connect with our leadership team to learn more: email us here
BIO One-on-One Partnering – JPM Week 2021
The Genomenon leadership team participated at the BIO Partnering during JP Morgan week 2021. To schedule a meeting, email us here.
Biotechgate Digital Partnering
Biotechgate Digital Partnering is focusing on companies developing drugs, diagnostics and medical devices. If we were unable to connect at this event, email us to schedule a meeting with our team.
Email us here
Orphan Drug & Rare Disease Global Congress
The two-day Congress provided an interactive, cutting edge and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry. Attendees collaborated on practical strategies and best practices on challenges, innovations, technologies and concepts surrounding orphan drugs and rare diseases. Co-founder and Chief Science Officer Dr. Mark Kiel presented ‘Big Data for Rare Disease: Comprehensive Genomic Landscapes to Accelerate Drug Development’. Email to learn more about our genomic solutions for Pharma.
Email us here
AMP 2020 Virtual Meeting & Expo
The 2020 AMP meeting explored how cutting-edge technology and developments in molecular testing and diagnostics continue to have a major impact on patient care, and ways in which our community remains at the forefront of precision medicine.
Learn more about this event
Biomarkers for Rare Non-Oncological Diseases Summit
The 2nd Annual Biomarkers for Rare Non-Oncological Diseases Summit united biopharma, diagnostic and healthcare teams to advance the application of precision medicine in rare diseases beyond oncology. If you were unable to visit our virtual booth, email us to schedule a meeting with our team to learn more about our genomic solutions.
Email us here
ASHG 2020 Virtual Meeting
The ASHG 2020 Virtual Meeting featured action-packed plenary & platform talks and invited sessions showcasing speakers who inspired and energized attendees with their cutting-edge research and ideas, including highlighting some of the most exciting work in genetics and genomics. If we missed you at ASHG 2020, email us to schedule a meeting with our leadership team.
Email us here
Bio-IT World Conference & Expo
Bio-IT World unites an ecosystem of over 3,000 leading life sciences, pharmaceutical, clinical, healthcare, informatics and technology experts in the field of biomedical research, drug discovery & development, and healthcare from around the world. Genomenon is a 2019 Bio-IT World Best in Show Award Winner.
If we missed you at this event, email our team to learn more about our genomic solutions for Pharma.
Email us here
Digital Clinical Biomarkers & World CDx
Uniting biomarker, translational, clinical, diagnostic and commercial thought leaders, the Digital Clinical Biomarkers & World CDx meeting addressed key questions raised following the rapid COVID-19 response and delivered exciting case studies from pioneering teams in personalized therapeutics. If we missed you at this event, email our team to learn more about our genomic solutions for Pharma.
Email us here
PREVIOUS EVENTS
June 8-12, 2020 – BIO Digital
The BIO International Convention transitioned to a new, virtual event format, BIO Digital. We were excited to have been a part of this virtual gathering of global biotech industry experts. Genomenon CEO, Mike Klein and CSO Dr. Mark Kiel partnered at this event thru the One-On-One Platform. If we were unable to connect at BIO, please email us below to connect with a member of our leadership team.
Email us here
June 11-12, 2020 – RARE Drug Development Symposium
Genomenon attended the RARE Drug Development Symposium, a two-day interactive virtual event in partnership with The Penn Medicine Orphan Disease Center that focused on educating both beginners and advanced participants on the drug development process. If we were unable to connect at RDDS, please email us below to connect with a member of our leadership team.
Email us here
June 6-8, 2020 – European Society of Human Genetics (ESHG)
Genomenon exhibited – virtual
The Genomenon team was looking forward to our first International event and after the change to a virtual format, we enjoyed connecting with attendees & speakers. If we were unable to connect at ESHG, please email us below to connect with a member of our leadership team.
Email us here
March 1- 4, 2020 – Molecular Med TRI-CON & Bio IT West
Genomenon exhibited at Booth #302
The International Molecular Medicine Tri-Conference, entering its 27th year, is one of the most comprehensive and leading industry events in the personalized medicine space today. The Tri-Conference brings together more than 3,100 innovative thinkers and thought leaders in the field of drug discovery, development and diagnostics, informatics, and digital health throughout pharma, biotech, and academia. If you were unable to schedule a meeting with our leadership team in San Francisco, you can contact us by sending us an email below.
Email us here
February 25-27, 2020 – 8th Annual Neurodegenerative Drug Development Summit
Genomenon attended
The Genomenon leadership team was in Boston for the 8th Annual Neurodegenerative Drug Development Summit. This event brought together over 150 neurodegeneration experts to enable them to overcome their translational challenges and successfully translate into the clinic. If we were unable to connect with you in Boston at this event, you can contact us by sending us an email below.
Email us here
January 13-15, 2020 – 2020 Digital Medicine & Medtech Showcase
Mike Klein, Genomenon’s CEO presented, “Leveraging A.I. and Genomics to Drive Rare Disease Drug Development” on Wednesday, January 15th, 2020 at 11:45 a.m. at the Parc 55 San Francisco hotel. If you were unable to attend this presentation, email us to learn more about Genomenon.
Email us here
January 12-16, 2020 – JP Morgan Healthcare Conference
Members of the Genomenon leadership team were in San Francisco during the JP Morgan Healthcare Conference, the most informative healthcare investment symposium in the industry. The conference brought together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
January 8, 2020 – BioArbor: Potential for AI and Machine Learning in Healthcare and Life Sciences
Genomenon founder & CTO Steve Schwartz was a featured panelist
Artificial intelligence. Machine learning. These buzzwords are the latest rage. But what do they really mean for the future of healthcare delivery and the life sciences industry? How are they being applied? Hear from a spectrum of viewpoints and backgrounds at the next BioArbor: Ann Arbor’s life science forum. BioArbor events are free and open to all bio-industry professionals and enthusiasts.
Learn more about BioArbor
November 12, 2019 – Cutting Edge/Drug Discovery & Development in Michigan
The Cutting Edge/Drug Discovery & Development in Michigan Symposium showcased drug R&D activities at the state’s research institutions and biotech/pharma companies and discuss their science, capabilities, and enterprises. Dr. Mark Kiel presented, “Curating the Genome to Drive Drug Discovery”.
View Dr. Kiel’s presentation
November 7-9, 2019 – Association for Molecular Pathology Annual Meeting & Expo (AMP)
The Genomenon team attended the 2019 AMP meeting – the premier gathering for molecular professionals. This year is the 25th anniversary and the technical advancements and legislative achievements were celebrated as the organization looks to the future and explores how to continue to provide the highest quality of care for patients in an evolving medical landscape.
Learn More
October 15-19, 2019 – American Society of Human Genetics Annual Meeting (ASHG)
At ASHG 2019 in Houston, Genomenon welcomed two leaders from UPMC and Rady Children’s Hospital who shared the tools and processes that are in place now, along with their plans for the future during a special CoLab session: How Rady Children’s Institute and University of Pittsburgh Medical Center are Automating Literature Curation and Variant Interpretation.
Learn More
October 10-11, 2019 – Precision Medicine Leaders Summit
Dr. Mark Kiel participated as a panelist during the Precision Medicine Leaders Summit moderated by Barbara Kraatz Fortini, PhD, Assistant Professor of Genetics and MSGDA Program Coordinator, School of Pharmacy and Health Science, Keck Graduate School. The event included the most thought-provoking Precision Medicine leaders in healthcare who are shaping the way Precision Medicine is implemented into healthcare systems on a global scale.
Learn More
September 11-12, 2019 – Clinical Biomarkers & World CDx
Dr. Mark Kiel presented on Optimizing Clinical Trial Design with Comprehensive Genomic Landscapes. Questions answered: What is the best way to understand the pathophysiology of a pathway or disease? How do you identify gene fusion partners to facilitate the development of targeted drugs?
Why is it important to understand the genomic landscape of a pathway or disease prior to selecting patient cohorts for clinical trials?
Learn More
June 15-18, 2019 – European Human Genetics Conference
Genomenon attended EHGS in Gothenburg, Sweden which provides workshops, instruction on human genetics and an environment to connect with others in the field of genetics from around the world. There were speakers from the various sectors of human genetics including educational talks, platform presentations and product exhibits for both clinical and laboratory work.
Learn More
June 3-6, 2019 – Bio International Convention
MIke Klein, CEO of Genomenon presented an overview on how Genomenon has partnered with pharmaceutical and bio-pharma customers to deliver a comprehensive genomic landscape around specific diseases for drug discovery and clinical trial target selection. The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Learn More
May 10, 2019 – Precision Genomics Midwest
PGM is the first Midwest regional conference focused exclusively on genomic research, translation and ethics.
The third annual Precision Genomics Midwest – the region’s largest genomics conference. PGM features talks by thought leaders in research, clinical, and translational genomics…and a top-quality vendor fair, showcasing the field’s leading-edge products and services.
Learn More
May 8-9, 2019 – Labroots Genetics and Genomics Virtual Event
Dr. Mark Kiel, CSO and Co-Founder of Genomenon presented on the topic of, “AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity”. Dr. Kiel will discussed challenges to automating variant interpretation while improving the accuracy and reproducibility of the process using Mastermind – the world’s most comprehensive literature-based Genomic Search Engine.
Learn More
April 16-18, 2019 – Bio-IT World Conference & Expo
Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad of IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives. Genomenon attented this special industry event.
Learn More
April 2-4, 2019 – The Annual Clinical Genetics Meeting
Genomenon exhibited at this event
Come visit us at Booth #620 to try Mastermind Genomic Search Engine, complete with ACMG variant classification filters. This tool quickly identifies and prioritizes articles which cite evidence for ACMG classification criteria for each variant, such as those that include functional studies, segregation information, and more. We will be giving away 100 decks of Variant Interpretation Cards. Come and get yours! Follow this link to request a meeting.
Learn More
March 28, 2019 – Webinar: Characterizing Targeted Cancer Therapies via a Comprehensive Gene Fusion Database
Co-Founder Mark Kiel hosts the upcoming webinar
Genomenon has developed the most comprehensive database of gene fusion pairs found within the scientific literature. This complete literature catalogue for the 507 genes from the Illumina TruSight RNA Fusion Panel contains all known fusion pairs, with reference citations for every scholarly paper citing the chimeric genes. In this webinar, Genomenon’s CSO and co-founder Dr. Mark Kiel discusses how a Gene Fusion Database can be used to facilitate drug discovery and development.
View the Recording
March 21, 2019 – Startup Story Night in Detroit
Co-Founder Mark Kiel will share the Genomenon startup story
The New Economy Initiative (NEI), in partnership with Model D Media, is excited to announce the 3rd annual Startup Story Night. This year’s theme? “Don’t Call It A Comeback!”
We’re happy to announce four storytellers have been selected to workshop their stories with Shannon Cason – host, MainStage storyteller and GrandSlam champion with The Moth – before performing them in front of a live audience at The Marble Bar on Thursday, March 21, 2019.
Learn More
March 10-15, 2019 – Molecular Med Tri-Con
Leading technology to achieve patient care
The event held discussions about Molecular professionals leading the way in developing and applying new technologies to achieve the best patient care and outcome in this rapidly evolving field. Additionally, how they also play a vital role in educating our clinical colleagues, lay public, and elected officials of the value of the critical work that we do.
Learn More
January 20-23, 2019 – The Precision Medicine World Conference
Precision Medicine strategies changing how patients are treated
The Precision Medicine World Conference (PMWC), in its 16th installment, will take place in the Santa Clara Convention Center (Silicon Valley). Conference attendees had an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
Learn More
November 1-3, 2018 – AMP – Association for Molecular Pathology Meeting & Expo
Genomenon will be exhibiting at AMP, booth #902
The event held discussions about Molecular professionals leading the way in developing and applying new technologies to achieve the best patient care and outcome in this rapidly evolving field. Additionally, how they also play a vital role in educating our clinical colleagues, lay public, and elected officials of the value of the critical work that we do.
Learn More
October 16-20, 2018 – ASHG – American Society of Human Genetics – Annual Meeting
Genomenon presented a CoLab and exhibitied at ASHG, booth #1134
This year’s meeting attracted over 6,500 scientific attendees, plus almost 250 exhibiting companies. The meeting provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Dr. Mark Kiel held the workshop: “Reconciling inconsistency among commercial NGS gene panels with an evidence-based curation platform: Impact Study Results.”
Learn More
October 11-12, 2018 – Oxford Global R&D US Series
Genomenon exhibited at the Biomarkers & Precision Medicine Congress
The R&D US Series unites over 350 attendees from global pharmaceutical organisations, top biotech companies and internationally renowned academic institutions, alongside 30+ leading solution providers such as Fios Genomics, Histologix, Avacta, Randox Biosciences, Axio Research, Metabolon, ChemAxon and many more.
Learn More
September 19, 2018 – Webinar: Is Genomic Medicine Ready for A.I.?
Dr. Mark Kiel presents his thoughts on current uses of artificial intelligence (AI) for genome interpretation, challenges to successful application in clinical medicine, and more.
Genome sequencing promises to improve diagnostic accuracy and patient outcomes in both oncology
and genetics, but the volume and complexity of the data requires a significant manual process to ensure high-quality interpretation. In the wake of IBM Watson, is Genomic Medicine Ready for AI?
Watch the Recording
August 8, 2018 – Researchpalooza
Researchpalooza is a free networking event hosted by the University of Michigan Medical School of Research.
Over 91 different offices and labs who serve biomedical research across the University of Michigan campus and beyond gather for this free ice cream social and networking event.
Learn More
July 11, 2018 – Webinar with Veritas Genetics
Accelerating Patient Diagnosis with Automated Literature Curation for Inherited Disease
This webinar with special guests from Veritas Genetics discussed an approach for automating variant classification using the American College of Medical Genetics and Genomics guidelines.
Watch the Recording
June 6-7, 2018 – Precision Medicine World Conference, Ann Arbor
The theme for this year’s PMWC is “Big Data in Action: Data-Driven Insights in the Clinic”
The program will feature innovative technologies, and analyze the success of already thriving initiatives and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Dr. Mark Kiel presented the talk “Is Genomic Medicine Ready for AI?”
June 15, 2018 – Tech Trek, Ann Arbor
Ann Arbor Tech Trek is a free community event and a terrific opportunity to see the real gems located in the Ann Arbor area
Leading technology companies will open their doors to the public and showcase their latest innovations. Whether you’re a job seeker, student, professional, or someone curious about the Ann Arbor tech community, anyone is welcome to attend. Genomenon demonstrated the Mastermind Genomic Search Engine at the event.
May 11, 2018 – Precision Genomics Midwest, Cincinnati
PGM is the first Midwest regional conference focused exclusively on genomic research, translation and ethics.
Genomenon exhibited and Dr. Mark Kiel will be speaking at the Precision Genomics Conference at Cincinnati Children’s in May.
April 10-14, 2018 – ACMG – Annual Clinical Genetics Meeting
American College of Medical Genetics and Genomics Meeting – Charlotte, N.C.
Presentation: Faster Patient Diagnosis: Automated ACMG Variant Classification
Speakers: Birgit Funke, PhD, Veritas Genetics; Mark Kiel, MD, PhD, Genomenon
April 3, 2018 – Webinar: Automated Biomarker Selection for Evidence-Based Gene Panel Design
Automated Biomarker Selection for Evidence-Based Gene Panel Design
Dr. Mark Kiel presented the biomarker selection process and results for the first comprehensive evidence-based Pan-Hematopoietic Malignancy Gene Panel using the Mastermind Genomic Search Engine.
Watch the Recording
Feb 15, 2018 – GenomeWeb Webinar
Mining Genomic Literature for Variant Interpretation and Gene Panel Design
University of Vermont Health System’s Dr. Nikoletta Sidiropoulos and Dr. David Seward discussed variant interpretation using Mastermind. Q2 Solution’s Dr. Vic Weigman presented an evidence-based design approach for gene panels using Mastermind.
Watch the Recording
MASTERMIND GENOMIC SEARCH ENGINE
The Largest Source of Genomic Literature
The Largest Source of Genomic Literature